SymBio Pharmaceuticals Limited (SYMQY)
OTCMKTS · Delayed Price · Currency is USD
0.9577
-0.0299 (-3.03%)
Sep 19, 2025, 12:50 PM EDT
SymBio Pharmaceuticals Market Cap
SymBio Pharmaceuticals has a market cap or net worth of $46.16 million as of September 19, 2025. Its market cap has decreased by -52.10% in one year.
Market Cap
46.16M
Enterprise Value
34.31M
Revenue
12.57M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.96
Market Cap Chart
Since October 20, 2011, SymBio Pharmaceuticals's market cap has decreased from 92.04M to 46.16M, a decrease of -49.85%. That is a compound annual growth rate of -4.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 19, 2025 | 46.16M | -20.47% |
| Dec 30, 2024 | 58.03M | -21.50% |
| Dec 29, 2023 | 73.93M | -61.62% |
| Dec 30, 2022 | 192.60M | -49.53% |
| Dec 30, 2021 | 381.62M | 172.51% |
| Dec 30, 2020 | 140.04M | -3.75% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 791.41M |
| Tian'an Technology Group | 728.29M |
| Elite Pharmaceuticals | 667.60M |
| Glass House Brands | 575.59M |
| Northwest Biotherapeutics | 373.76M |
| Nika Pharmaceuticals | 370.64M |
| CytoDyn | 367.01M |
| American Oncology Network | 340.34M |